Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: a meta-analysis
| Autor: | Jinhang Gao, Cheng Wei Tang, Ling Liu, Huan Tong, Yan Hua Chen, Rui Liu, Can Gan |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
safety
medicine.medical_specialty efficacy Subgroup analysis pancreatic enzyme replacement therapy Cochrane Library Placebo law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Internal medicine medicine 030212 general & internal medicine Exocrine pancreatic insufficiency standardization business.industry medicine.disease exocrine pancreatic insufficiency Jadad scale Surgery Clinical trial Oncology Meta-analysis 030211 gastroenterology & hepatology business Meta-Analysis |
| Zdroj: | Oncotarget |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.21659 |
| Popis: | // Can Gan 1, 2, * , Yan-Hua Chen 1, 2, * , Ling Liu 1, 2 , Jin-Hang Gao 1 , Huan Tong 1, 2 , Cheng-Wei Tang 1, 2 and Rui Liu 1 1 Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China 2 Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China * These authors contributed equally to this work and should be considered as co-first authors Correspondence to: Cheng-Wei Tang, email: shcqcdmed@163.com Rui Liu, email: lrui60@163.com Keywords: pancreatic enzyme replacement therapy, exocrine pancreatic insufficiency, efficacy, safety, standardization Received: July 12, 2017 Accepted: September 21, 2017 Published: October 07, 2017 ABSTRACT Background: Pancreatic enzyme replacement therapy (PERT) is widely applied to patients with exocrine pancreatic insufficiency (EPI), but its effect and safety has not been quantified. Therefore we performed a meta-analysis to determine the efficacy and tolerance of PERT on patients with EPI. Materials and Methods: PubMed, Medline, Cochrane library database, Evidence-based medicine/clinical trials published before December 2016 were searched by two independent reviewers to identify prospective randomized controlled trials (RCTs). Results: Seven RCTs, randomizing a total of 282 patients, were filtrated and assessed qualitatively (Jadad score). PERT increased CFA (WMD: 26.56, 20.35 to 32.76, I 2 = 79.6%, P < 0.001) compared with baseline, and CFA (WMD: 17.97, 12.61 to 23.34, I 2 = 76.7%, P < 0.001) vs. placebo. Meanwhile, CNA, SFE, SNE and SW were significantly improved in PERT compared with baseline and placebo, with no statistical differences in adverse events. Subgroup analysis indicated that standard forms of PERT displayed more effectiveness with significantly decreased heterogeneity, and large sample size also reduced the heterogeneity to some degree. Conclusions: PERT is demonstrated to be effective and tolerable in patients with EPI, especially using standard administration of PERT. Larger and higher quality studies on EPI are demanded to long-term effect of standard PERT treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|